Back to top
more

Addus HomeCare (ADUS)

(Delayed Data from NSDQ)

$133.58 USD

133.58
114,705

+1.19 (0.90%)

Updated Aug 23, 2024 03:59 PM ET

After-Market: $133.46 -0.12 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Option Care (OPCH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 3.55% and 5.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?

Here is how Amphastar Pharmaceuticals (AMPH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

Addus HomeCare (ADUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Philips (PHG) Drives Healthcare Prospects With Enhanced Dataset

Philips (PHG) announces its expansion with MIT IMES, which will help researchers and educators access a new critical care dataset.

ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Are Medical Stocks Lagging Humana (HUM) This Year?

Here is how Humana (HUM) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

Philips (PHG) Inks 7-Year Partnership With Northwell Health

Philips (PHG) announces that it has entered into a seven-year agreement with Northwell Health, one of the largest healthcare providers in the state of New York.

Philips (PHG) Drives Health Care Prospects With New Solutions

Philips (PHG) announces Philips Virtual Care Management solutions, which provide a comprehensive approach to telehealth for patients, providers and payers.

Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?

Here is how Addus HomeCare (ADUS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group

Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.

Here's Why You Should Retain HCA Healthcare (HCA) Stock Now

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and sufficient cash-generating abilities.

Debanjana Dey headshot

4 Promising Stocks From a Challenging Outpatient Home Health Industry

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.

ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Is Addus HomeCare (ADUS) Outperforming Other Medical Stocks This Year?

Here is how Addus HomeCare (ADUS) and Alcon (ALC) have performed compared to their sector so far this year.

What Makes Addus HomeCare (ADUS) a New Buy Stock

Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Addus HomeCare (ADUS) Q4 Earnings and Revenues Beat Estimates

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 14.43% and 0.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Surpasses Q4 Earnings and Revenue Estimates

Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Reports Next Week: What to Expect

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights Option Care Health, LifeStance Health, Addus HomeCare and Pennant

Option Care Health, LifeStance Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.

4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.

Addus HomeCare (ADUS) Tops Q3 Earnings Estimates

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 1.08% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Reports Next Week: Wall Street Expects Earnings Growth

Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.